PTC Therapeutics Newsroom

PTC Therapeutics Raised to Overweight From Equal-Weight by Morgan Stanley

Dow JonesDec 14 02:02

PTC Therapeutics Analyst Ratings

BenzingaDec 14 01:53

RBC Capital Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsDec 13 20:33

PTC Therapeutics (PTCT) Receives a Buy From RBC Capital

TipRanksDec 13 20:11

Morgan Stanley Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $67

Futu NewsDec 13 18:33

Morgan Stanley Upgrades PTC Therapeutics(PTCT.US) to Buy Rating, Raises Target Price to $67

Futu NewsDec 13 09:32

PTC Therapeutics: Hold Rating Amid Strategic Collaboration With Novartis and Clinical Uncertainties

TipRanksDec 6 13:58

Citi Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $32

Futu NewsDec 6 00:36

PTC Therapeutics Is Maintained at Sell by Citigroup

Dow JonesDec 5 00:39

Goldman Sachs Maintains Sell on PTC Therapeutics, Raises Price Target to $42

BenzingaDec 4 22:22

Barclays Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Raises Target Price to $56

Futu NewsDec 4 18:33

A Quick Look at Today's Ratings for PTC Therapeutics(PTCT.US), With a Forecast Between $41 to $68

Futu NewsDec 3 21:01

UBS Raises PTC Therapeutics Price Target to $71 From $47, Maintains Buy Rating

MT NewswiresDec 3 20:56

PTC Therapeutics Is Maintained at Equal-Weight by Barclays

Dow JonesDec 3 20:29

PTC Therapeutics Analyst Ratings

BenzingaDec 3 20:20

Baird Maintains Outperform on PTC Therapeutics, Raises Price Target to $70

BenzingaDec 3 20:20

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)

TipRanksDec 3 18:52

PTC Therapeutics' Strategic Collaboration With Novartis Boosts Buy Rating

TipRanksDec 3 02:18

Hold Recommendation for PTC Therapeutics: Balancing Promising Prospects With Regulatory and Competitive Challenges

TipRanksDec 2 23:57

RBC Capital Remains a Hold on PTC Therapeutics (PTCT)

TipRanksNov 28 09:49